GURUFOCUS.COM » STOCK LIST » Technology » Software » NCI Inc (NAS:NCIT) » Definitions » PS Ratio

NCI (NCIT) PS Ratio : 0.84 (As of May. 12, 2024)


View and export this data going back to 2005. Start your Free Trial

What is NCI PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, NCI's share price is $20.00. NCI's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2017 was $23.75. Hence, NCI's PS Ratio for today is 0.84.

The historical rank and industry rank for NCI's PS Ratio or its related term are showing as below:

NCIT's PS Ratio is not ranked *
in the Software industry.
Industry Median: 2.275
* Ranked among companies with meaningful PS Ratio only.

NCI's Revenue per Sharefor the three months ended in Jun. 2017 was $6.46. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2017 was $23.75.

Back to Basics: PS Ratio


NCI PS Ratio Historical Data

The historical data trend for NCI's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NCI PS Ratio Chart

NCI Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 0.26 0.43 0.56 0.60

NCI Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 0.49 0.60 0.65 0.88

Competitive Comparison of NCI's PS Ratio

For the Information Technology Services subindustry, NCI's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NCI's PS Ratio Distribution in the Software Industry

For the Software industry and Technology sector, NCI's PS Ratio distribution charts can be found below:

* The bar in red indicates where NCI's PS Ratio falls into.



NCI PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

NCI's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=20.00/23.753
=0.84

NCI's Share Price of today is $20.00.
NCI's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $23.75.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


NCI  (NAS:NCIT) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


NCI PS Ratio Related Terms

Thank you for viewing the detailed overview of NCI's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


NCI (NCIT) Business Description

Traded in Other Exchanges
N/A
Address
NCI Inc is a Delaware corporation incorporated in July 2005. The Company provides enterprise services and solutions to Defense, Intelligence, Healthcare, and Civilian Government agencies. The Company provides services in areas including cybersecurity and information assurance; engineering and logistics support; enterprise information management and advanced analytics; cloud computing and information technology (IT) infrastructure optimization; health IT and medical support; IT service management; and modeling, simulation and training. The Company uses an integrated, tailorable engineering and operations methodology for governing how it provides cloud computing and IT infrastructure optimization services that fulfill its customer's important mission needs. It supports Department of Defense (DoD) weapon systems lifecycle support efforts in diminishing manufacturing sources and material shortages (DMSMS) analysis and engineering solutions in support of modernization and technology insertion. It supports rapid and relevant discovery, anticipatory intelligence, focused analysis, and persistent surveillance across multiple customer domains and operational disciplines as well as enriches the intelligence-to-operations lifecycle by applying scalable technologies and advanced algorithms to help interpret data. The Company provides a broad spectrum of health IT services experience, including cybersecurity/IA, Health Insurance Portability and Accountability Act (HIPPA) and Federal Information Security Management Act (FISMA) compliance, data analysis/management. The Company designs, installs, and manages complex mission-critical enterprise systems for its customers, increasing the reliability, security, and efficiency of their IT operations while meeting stringent guidelines and requirements. The Company often competes against or team with divisions of Defense and IT services contractors, including Lockheed Martin Corporation, Northrop Grumman Corporation, General Dynamics Corporation, Computer Sciences Corporation, Raytheon, Harris, BAE Systems, Booz Allen Hamilton, Leidos, and Science Applications International Corporation (SAIC). It also competes against or team with mid-tier Federal contractors, such as CACI International and ManTech International that have specialized capabilities, as well as numerous non-public companies within the sector. The Company is subject to various laws and regulations that may affect its business. U.S. Federal Government contracts are subject to a number of Federal laws and regulations, including the Federal Acquisition Regulation (FAR).
Executives
Yerks Austin J. Iii director 9404 LAGOVISTA COURT, GREAT FALLS VA 22066
James P Allen director C/O GRC INTERNATIONAL INC, 1900 GALLOWS RD, VIENNA VA 22182
Philip O Nolan director 15052 CONFERENCE CENTER DRIVE, CHANTILLY VA 20151
Stephen L Waechter director 1100 N GLEBE ROAD, ARLINGTON VA 22201
Judith L Bjornaas officer: Executive VP and CFO 12015 LEE JACKSON MEMORIAL HWY., MANTECH INTERNATIONAL CORPORATION, FAIRFAX VA 22033

NCI (NCIT) Headlines

From GuruFocus

NCI Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 11-05-2009

NCI Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 05-06-2010

NCI Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 11-04-2010

NCI Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 08-05-2010

NCI Inc. Reports Operating Results (10-K)

By gurufocus 10qk 02-28-2011

NCI Inc. Reports Operating Results (10-Q)

By gurufocus 08-06-2009

NCI Inc. Reports Operating Results (10-Q)

By gurufocus 05-08-2009